North South Ventures is built around two academic-medical hubs—Stanford/UCSF and the University of Toronto—and is run by a team that includes a former University of Toronto president, a former MaRS CEO, and other health and biotech veterans, giving it access to seed deals from top U.S. and Canadian institutions that are usually hard for outside investors to reach. Its portfolio spans frontier healthcare bets like a non-hormonal male contraceptive pill, embryo genetic screening, and reversible neural hearing implants, along with international deep-science and biotech companies in places like Spain and Australia, and includes a notably high share of women-founded startups across multiple areas of healthcare.